Development and characterisation of a novel three-dimensional inter-kingdom wound biofilm model

Biofouling

Volumn 32, Issue 10, 2016, Pages 1259-1270

  Townsend, Eleanor M ^a,b   Sherry, Leighann ^a,b   Rajendran, Ranjith ^a   Hansom, Donald ^a   Butcher, John ^b   Mackay, William G ^b   Williams, Craig ^b   Ramage, Gordon ^a  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

biofilm; Chronic wound; in vitro model; interkingdom; polymicrobial

Indexed keywords

BIOFILM; CELLULOSE; DYE; MICROBIAL COMMUNITY; PRINCIPAL COMPONENT ANALYSIS; WOUNDING;

CANDIDA ALBICANS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; HYDROGEL;

BIOFILM; BIOLOGICAL MODEL; CANDIDA ALBICANS; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HYDROGEL; MICROBIOLOGY; PHYSIOLOGY; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

ANTI-INFECTIVE AGENTS; BIOFILMS; CANDIDA ALBICANS; HYDROGEL; MODELS, BIOLOGICAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; WOUND HEALING; WOUND INFECTION;

EID: 84995380225     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2016.1252337     Document Type: Article

References (59)

1. Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG, Woo K, Boeni T, Ayello EA, Kirsner RS. 2014. Diabetic foot ulcers:part II. Management. J Am Acad Dermatol. 70:21. e21-21. e24.
2. Alvarez G, Gonzalez M, Isabal S, Blanc V, Leon R. 2013. Method to quantify live and dead cells in multi-species oral biofilm by real-time PCR with propidium monoazide. AMB Express. 3:1. doi:10.1186/2191-0855-3-1
3. Atiyeh BS, Dibo SA, Hayek SN. 2009. Wound cleansing, topical antiseptics and wound healing. Int Wound J. 6:420–430. doi:10.1111/iwj.2009.6.issue-6
4. Capita, R, Riesco-Peláez F, Alonso-Hernando A, Alonso-Calleja C. 2014. Exposure of Escherichia coli ATCC 12806 to sublethal concentrations of food-grade biocides influences its ability to form biofilm, resistance to antimicrobials, and ultrastructure. Appl Environ Microbiol. 80:1268–1280. doi:10.1128/AEM.02283-13
5. Castillo M, Martín-Orúe SM, Manzanilla EG, Badiola I, Martín M, Gasa J. 2006. Quantification of total bacteria, enterobacteria and lactobacilli populations in pig digesta by real-time PCR. Vet Microbiol.114:165–170. doi:10.1016/j.vetmic.2005.11.055
6. Citron DM, Goldstein EJ, Merriam CV, Lipsky BA, Abramson MA. 2007. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol. 45:2819–2828. doi:10.1128/JCM.00551-07
7. Clutterbuck AL, Cochrane CA, Dolman J, Percival SL. 2007. Evaluating antibiotics for use in medicine using a poloxamer biofilm model. Ann Clin Microbiol Antimicrob. 6:1.
8. Davies D. 2003. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2:114–122. doi:10.1038/nrd1008
9. Dowd S, Sun Y, Smith E, Kennedy J, Jones C, Wolcott R. 2009. Effects of biofilm treatments on the multi-species Lubbock chronic wound biofilm model. J Wound Care. 18:508–512.
10. Dowd SE, Delton Hanson J, Rees E, Wolcott RD, Zischau AM, Sun Y, White J, Smith DM, Kennedy J, Jones CE. 2011. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care. 20:40–47. doi:10.12968/jowc.2011.20.1.40
11. Duthie E, Lorenz LL. 1952. Staphylococcal coagulase:mode of action and antigenicity. Microbiology. 6:95–107. doi:10.1099/00221287-6-1-2-95
12. Erlandsen SL, Kristich CJ, Dunny GM, Wells CL. 2004. High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy:dependence on cationic dyes. J Histochem Cytochem. 52:1427–1435. doi:10.1369/jhc.4A6428.2004
13. Fazli M, Bjarnsholt T, Kirketerp-Møller K, Jørgensen B, Andersen AS, Krogfelt KA, Givskov M, Tolker-Nielsen T. 2009. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol. 47:4084–4089. doi:10.1128/JCM.01395-09
14. Fonzi WA, Irwin MY. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics. 134:717–728.
15. Grice EA, Segre JA. 2011. The skin microbiome. Nat Rev Microbiol. 9:244–253. doi:10.1038/nrmicro2537
16. Hammer Ø, Harper DAT, Ryan PD. 2001. PAST:Paleontological statistics software package for education and data analysis. Palaeontolia Electronica 4. http://palaeo-electronica.org/2001_1/past/issue1_01.htm
17. Harrison F, Roberts AE, Gabrilska R, Rumbaugh KP, Lee C, Diggle SP. 2015. A 1,000-year-old antimicrobial remedy with antistaphylococcal activity. mBio. 6:e01129–01115.
18. Hartemann-Heurtier A, Robert J, Jacqueminet S, Ha Van G, Golmard J, Jarlier V, Grimaldi A. 2004. Diabetic foot ulcer and multidrug-resistant organisms:risk factors and impact. Diabet Med. 21:710–715. doi:10.1111/dme.2004.21.issue-7
19. He J-W, Jiang S. 2005. Quantification of enterococci and human adenoviruses in environmental samples by real-time PCR. Appl Environ Microbiol. 71:2250–2255. doi:10.1128/AEM.71.5.2250-2255.2005
20. Hex N, Bartlett C, Wright D, Taylor M, Varley D. 2012. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 29:855–862. doi:10.1111/j.1464-5491.2012.03698.x
21. Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW. 2010. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother. 65:1195–1206.
22. Hoekstra MJ, Westgate SJ, Mueller S. 2016. Povidone‐iodine ointment demonstrates in vitro efficacy against biofilm formation. Int Wound J. doi:10.1111/iwj.12578
23. Hogan DA, Kolter R. 2002. Pseudomonas-Candida interactions:an ecological role for virulence factors. Science. 296:2229–2232. doi:10.1126/science.1070784
24. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322–332. doi:10.1016/j.ijantimicag.2009.12.011
25. James GA, Swogger E, Wolcott R, Secor P, Sestrich J, Costerton JW, Stewart PS. 2008. Biofilms in chronic wounds. Wound Repair Regen. 16:37–44. doi:10.1111/wrr.2008.16.issue-1
26. Kanno E, Tanno H, Suzuki A, Kamimatsuno R, Tachi M. 2016. Reconsideration of iodine in wound irrigation:the effects on Pseudomonas aeruginosa biofilm formation. J Wound Care. 25:335–339. doi:10.12968/jowc.2016.25.6.335
27. Kart D, Tavernier S, Van Acker H, Nelis HJ, Coenye T. 2014. Activity of disinfectants against multispecies biofilms formed by Staphylococcus aureus, Candida albicans and Pseudomonas aeruginosa. Biofouling. 30:377–383. doi:10.1080/08927014.2013.878333
28. Kirchner S, Fothergill JL, Wright EA, James CE, Mowat E, Winstanley C. 2012. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung. J Vis Exp:JoVE. 64:e3857.
29. MacDonald YG, Hait H, Lipsky B, Zasloff M, Holroyd K. 2002. Microbiological profile of infected diabetic foot ulcers. Diabet Med. 19:1032–1034. doi:10.1046/j.1464-5491.2002.00696_1.x
30. Mariscal A, Lopez-Gigosos RM, Carnero-Varo M, Fernandez-Crehuet J. 2009. Fluorescent assay based on resazurin for detection of activity of disinfectants against bacterial biofilm. Appl Microbiol Biotechnol. 82:773–783.
31. Miles A, Misra S, Irwin J. 1938. The estimation of the bactericidal power of the blood. J Hyg. 38:732–749. doi:10.1017/S002217240001158X
32. Mottola C, Matias CS, Mendes JJ, Melo-Cristino J, Tavares L, Cavaco-Silva P, Oliveira M. 2016. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections. BMC Microbiol. 16:1–19. doi:10.1186/s12866-016-0737-0
33. Naparstek L, Carmeli Y, Navon-Venezia S, Banin E. 2014. Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 69:1027–1034. doi:10.1093/jac/dkt487
34. Neut D, Tijdens-Creusen EJ, Bulstra SK, Van der Mei HC, Busscher HJ. 2011. Biofilms in chronic diabetic foot ulcers-a study of 2 cases. Acta Orthopaedica. 82:383–385. doi:10.3109/17453674.2011.581265
35. Norman G, Dumville JC, Moore ZE, Tanner J, Christie J, Goto S. 2015. Antibiotics and antiseptics for pressure ulcers. Chichester:The Cochrane Library/Wiley.
36. O’Meara S, Al-Kurdi D, Ologun Y, Ovington LG, Martyn-St James M, Richardson R. 2013. Antibiotics and antiseptics for venous leg ulcers. Cochrane Database Syst Rev. 12:1–194.
37. O’Meara S, Cullum N, Majid M, Sheldon T. 2001. Systematic review of antimicrobial agents used for chronic wounds. Br J Surg. 88:4–21. doi:10.1046/j.1365-2168.2001.01631.x
38. Percival SL, Bowler PG, Dolman J. 2007. Antimicrobial activity of silver‐containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J. 4:186–191. doi:10.1111/iwj.2007.4.issue-2
39. Peters BM, Jabra-Rizk MA, Graeme A, Costerton JW, Shirtliff ME. 2012. Polymicrobial interactions:impact on pathogenesis and human disease. Clin Microbiol Rev. 25:193–213. doi:10.1128/CMR.00013-11
40. Pozo J, Patel R. 2007. The challenge of treating biofilm‐associated bacterial infections. Clin Pharmacol Ther. 82:204–209. doi:10.1038/sj.clpt.6100247
41. Rahme LG, Stevens EJ, Wolfort SF, Shao J. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science. 268:1899–1900. doi:10.1126/science.7604262
42. Ramage G, Rajendran R, Sherry L, Williams C. 2012. Fungal biofilm resistance. Int J Microbiol. 2012:528521.
43. Ramage G, Zalewska A, Cameron DA, Sherry L, Murray C, Finnegan MB, Loewy ZG, Jagger DC. 2012. A comparative in vitro study of two denture cleaning techniques as an effective strategy for inhibiting Candida albicans biofilms on denture surfaces and reducing inflammation. J Prosthodont. 21:516–522. doi:10.1111/jopr.2012.21.issue-7
44. Rani SA, Pitts B, Beyenal H, Veluchamy RA, Lewandowski Z, Davison WM, Buckingham-Meyer K, Stewart PS. 2007. Spatial patterns of DNA replication, protein synthesis, and oxygen concentration within bacterial biofilms reveal diverse physiological states. J Bacteriol. 189:4223–4233. doi:10.1128/JB.00107-07
45. Salami AA, Imosemi IO, Owoeye OO, Salami A, Imosemi I, Owoeye O. 2006. A comparison of the effect of chlorhexidine, tap water and normal saline on healing wounds. Int J Morphol. 24:673–676.
46. Sanchez MC, Marin MJ, Figuero E, Llama-Palacios A, Herrera D, Sanz M. 2013. Analysis of viable vs. dead Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis using selective quantitative real-time PCR with propidium monoazide. J Periodontal Res. Apr;48:213–220. doi:10.1111/jre.2013.48.issue-2
47. Sanchez MC, Marin MJ, Figuero E, Llama-Palacios A, Leon R, Blanc V, Herrera D, Sanz M. 2014. Quantitative real-time PCR combined with propidium monoazide for the selective quantification of viable periodontal pathogens in an in vitro subgingival biofilm model. J Periodontal Res. Feb;49:20–28. doi:10.1111/jre.12073
48. Santos R, Gomes D, Macedo H, Barros D, Tibério C, Veiga AS, Tavares L, Castanho M, Oliveira M. 2016. Guar gum as a new antimicrobial peptide delivery system against diabetic foot ulcers Staphylococcus aureus isolates. J Med Microbiol. 65:1092–1099.
49. Santucci S, Gobara S, Santos C, Fontana C, Levin A. 2003. Infections in a burn intensive care unit:experience of seven years. J Hosp Infect. 53:6–13. doi:10.1053/jhin.2002.1340
50. Sherry L, Millhouse E, Lappin DF, Murray C, Culshaw S, Nile CJ, Ramage G. 2013. Investigating the biological properties of carbohydrate derived fulvic acid (CHD-FA) as a potential novel therapy for the management of oral biofilm infections. BMC Oral Health. 13:15–25. doi:10.1186/1472-6831-13-47
51. Sherry L, Lappin G, O’Donnell L, Millhouse E, Millington OR, Bradshaw D, Axe A, Williams C, Nile CJ, Ramage G. 2016. Viable compositional analysis of an eleven species oral polymicrobial biofilm. Frontiers Microbiol. 7:912–925.
52. Smith K, Collier A, Townsend EM, O’Donnell LE, Bal AM, Butcher J, Mackay WG, Ramage G, Williams C. 2016. One step closer to understanding the role of bacteria in diabetic foot ulcers:characterising the microbiome of ulcers. BMC Microbiol. 16:54–66.
53. Snell JA, Loh N, Mahambrey T, Shokrollahi K. 2013. Clinical review:the critical care management of the burn patient. Crit Care. 17:241–251. doi:10.1186/cc12706
54. Strathmann M, Griebe T, Flemming H-C. 2000. Artificial biofilm model–a useful tool for biofilm research. Appl Microbiol Biotechnol. 54:231-237. doi:10.1007/s002530000370
55. Sun Y. 2010. Survey of fungi and yeast in polymicrobial infections in chronic wounds. J Wound Care. 20:40–47.
56. Tote K, Horemans T, Berghe DV, Maes L, Cos P. 2010. Inhibitory effect of biocides on the viable masses and matrices of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Appl Environ Microbiol. 76:3135–3142. doi:10.1128/AEM.02095-09
57. Touzel R, Sutton J, Wand M. 2016. Establishment of a multi-species biofilm model to evaluate chlorhexidine efficacy. J Hosp Infect. 92:154–160. doi:10.1016/j.jhin.2015.09.013
58. Weinstein RA, Mayhall CG. 2003. The epidemiology of burn wound infections:then and now. Clin Infect Dis. 37:543–550. doi:10.1086/376993
59. Zhang W, McLamore ES, Garland N, Leon JC, Banks MK. 2013. A simple method for quantifying biomass cell and polymer distribution in biofilms. J Microbiol Methods. 94:367–374.